Author

Rae M. Myers

Observed names: R M Myers, R Myers, Rae M Myers, Rae Myers

Observed institution: Mayo Clinic

OpenAlex ID: A5032895494

Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide

2007 · R M Myers, S M Greiner, et al. · Clinical Pharmacology & Therapeutics · 126

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

2006 · Boris Blechacz, Patrick L. Splinter, et al. · Hepatology · 112

Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses

2012 · K-W Peng, R Myers, et al. · Gene Therapy · 96

Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas

2008 · Rae Myers, Mary Harvey, et al. · Human Gene Therapy · 86

Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates

2009 · Nathan Jenks, Rae Myers, et al. · Human Gene Therapy · 75

Oncolytic measles virus strains in the treatment of gliomas

2008 · Cory Allen, Georgia Paraskevakou, et al. · Expert Opinion on Biological Therapy · 73

Dynamics of multiple myeloma tumor therapy with a recombinant measles virus

2009 · D Dingli, C Offord, et al. · Cancer Gene Therapy · 69

Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer

2005 · Rae Myers, Suzanne Greiner, et al. · Cancer Gene Therapy · 68

A Preclinical Large Animal Model of Adenovirus-Mediated Expression of the Sodium–Iodide Symporter for Radioiodide Imaging and Therapy of Locally Recurrent Prostate Cancer

2005 · Roisin M. Dwyer, Stephen M. Schatz, et al. · Molecular Therapy · 62

Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus

2012 · Ianko D Iankov, Cory Allen, et al. · Molecular Therapy · 59

Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model

2006 · K-W Peng, E M Hadac, et al. · Cancer Gene Therapy · 59

Biodistribution of Oncolytic Measles Virus After Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

2003 · Kah-Whye Peng, Marie Frenzke, et al. · Human Gene Therapy · 55

Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy

2012 · H V Reddi, P Madde, et al. · Cancer Gene Therapy · 48

Preclinical safety and activity of recombinant VSV‐IFN‐β in an immunocompetent model of squamous cell carcinoma of the head and neck

2013 · Vittal V. S. Kurisetty, Joshua Heiber, et al. · Head & Neck · 24

297. Safety of Repeat Intracerebral Administration of MV-CEA in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas

2006 · Rae M. Myers, Mary E. Harvey, et al. · Molecular Therapy · 5

Improving Delivery of Oncolytic Viruses to Solid Tumours

2014 · R Carlisle, Shvaĭger Mo, et al. · ASEP

Pre-Clinical Data and Preliminary Patient Results of Intravenous MV-NIS To Treat Relapsed, Refractory Multiple Myeloma.

2007 · Angela Dispenzieri, Rae M. Myers, et al. · Blood

Works count: 17

Citation count: 1,017

H-index: 14

I10-index: 14